Wednesday, October 31, 2007

New Drug Developments

There’s lots of activity going on in development of HIV medications. During the month of October 2007, there have been two new drugs approved in Canada and one new drug approved in the United States. Atripla is now available in Canada. It becomes the first once-daily single tablet formulation (contains Sustiva, Tenofovir and Emtricitabine all in one pill). Maraviroc, also approved in Canada, is a new entry inhibitor. Raltegravir, an integrase inhibitor, has gained approval in the U.S. and is expected to be given approval in Canada soon. This is all good news, giving those who are developing drug resistance hope for the future. What are your thoughts on new drug developments? Have you had experience with any of these new drugs through clinical trials?

No comments: